FdaApplication
NDA 021897
Identifiers
- fda_app_no: NDA021897
Properties
| Property | Value |
|---|---|
| applicant_name | ALKERMES INC |
| application_type | NDA |
| approval_date | 2006-04-13 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| VIVITROL | NALTREXONE | 380MG/VIAL | FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR |
1 product